The I-neb Adaptive Aerosol Delivery (AAD) System

MedicaMundi

Volumn 54, Issue 3, 2010, Pages 54-58

  Denyer, John ^a   Nikander, Kurt ^b  

^a Respiratory Drug Delivery UK Ltd   (United Kingdom)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; ILOPROST; PROMIXIN; UNCLASSIFIED DRUG;

AEROSOL; ALGORITHM; ARTICLE; BREATHING PATTERN; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; HUMAN; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; POWDER INHALER; PULMONARY HYPERTENSION;

EID: 78649769650     PISSN: 00257664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nikander K, Denyer J. Breathing Patterns. Eur Respir Rev. 2000; 10(76):576-579.
2. Nikander K. Adaptive Aerosol Delivery: the Principles. Eur Respir Rev. 1997; 7:385-387.
3. Denyer J. Adaptive Aerosol Delivery in Practice. Eur Respir Rev. 1997; 7:388-389.
4. Denyer J, Nikander K, Smith NJ. Adaptive Aerosol Delivery (AAD) Technology. Expert Opin Drug Deliv. 2004; 1(1):165-76.
5. Nikander K, Denyer J. Adaptive Aerosol Delivery (AAD) Technology. In: Rathbone MJ (ed). Modified Release Drug Delivery Technology, 2nd ed. Informa Healthcare USA, Inc., New York, NY; 603-612, 2008.
6. Denyer J, Dyche T. The Adaptive Aerosol Delivery (AAD) Technology: Past, Present and Future. J Aerosol Med Pulm Drug Del. 2010; 23 (Suppl 1):S1-S10. http://www.liebertonline.com/toc/jamp/23/s1
7. Hardaker LE, Hatley RHM. In Vitro Characterization of the I-neb Adaptive Aerosol Delivery (AAD) System. J Aerosol Med Pulm Drug Del. 2010; 23 (Suppl 1):S11-S20. http://www.liebertonline. com/toc/jamp/23/s1
8. McNamara P, McCormack P, McDonald AJ, Heaf L, Southern KW. Open Adherence Monitoring using Data Download from an Adaptive Aerosol Delivery Nebulizer in Children with Cystic Fibrosis. J Cystic Fibrosis. 2009; 8:258-263.
9. Olschewski H, Simonneau G, Galie N, Higenbottam T, Naeije, Rubin LJ. Inhaled Iloprost for Severe Pulmonary Hypertension. NEJM. 2002; 347:322-329.
10. Denyer J, Prince I, Dixon E, Agent P, Pryor J, Hodson M. Evaluation of the Target Inhalation Mode (TIM) Breathing Maneuver in Simulated Nebulizer Therapy in Patients with Cystic Fibrosis. J Aerosol Med Pulm Drug Del. 2010; 23 (Suppl 1):S29-S36. http://www.liebertonline.com/toc/jamp/23/s1
11. Denyer J, Black A, Nikander K, Dyche T, Prince I. Domiciliary Experience of the Target Inhalation Mode (TIM) Breathing Maneuver in Patients with Cystic Fibrosis. J Aerosol Med Pulm Drug Del. 2010; 23 (Suppl 1):S45-S54. http://www.liebertonline. com/toc/jamp/23/s1
12. Nikander K, Prince I, Coughlin S, Warren S, Taylor G. Mode of Breathing - Tidal or Slow and Deep - Through the I-Neb Adaptive Aerosol Delivery (AAD) System Affects Lung Deposition of 99mTc- DTPA. J Aerosol Med Pulm Drug Del. 2010; 23 (Suppl 1):S37-S43. http://www.liebertonline.com/toc/jamp/23/s1
13. Goodman N, Morgan M, Nikander K, Hinch S, Coughlin S. Evaluation of Patient-reported Outcomes and Quality of Life with the I-neb AAD System in Patients with Chronic Obstructive Pulmonary Disease. J Aerosol Med Pulm Drug Del. 2010; 23(Suppl 1):S61-S70. http://www.liebertonline.com/toc/jamp/23/s1
14. Cystic Fibrosis Trust. Antibiotic Treatment for Cystic Fibrosis. Report of the UK Cystic Fibrosis Trust Antibiotic Working Group - 3rd edition, May 2009. http://www.cftrust.org.uk/aboutcf/publications/consensusdoc/Antibiotic_treatment_for_Cystic_Fibrosis.pdf